Cutler Group LP Arcutis Biotherapeutics, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	BUY	$13.96 - $20.4 $279,200 - $408,000	20,000 New	20,000 $8,000
Q1 2022 Apr 14, 2022	BUY	$14.38 - $22.79 $18,694 - $29,627	1,300 New	1,300 $2,000
Q3 2021 Oct 26, 2021	SELL	$19.28 - $27.1 $75,192 - $105,690	-3,900 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$24.42 - $34.75 $19,536 - $27,800	-800 Reduced 17.02%	3,900 $9,000
Q1 2021 Apr 26, 2021	BUY	$24.47 - $36.98 $115,009 - $173,805	4,700 New	4,700 $9,000

193

127M

5.43M

257K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $575M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.